Public tenders in Germany

260 open tenders

CountryTenderValueClosesDays left

Conclusion of a non-exclusive discount agreement for medicines under § 130a Abs. 8 SGB V via an Open-House model for the active substance Teriparatide (WHO ATC-code: H05AA02)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 686726-2025

value not stated1 lot

Mon 31 Jan23:58 in Berlin

459days

Non-exclusive Drug Discount Agreement under § 130a Abs. 8 SGB V via Open-House Model for the Active Substance Lisdexamfetamine, Excluding Hard Capsules/Capsules with Pack Size 30 pieces

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 806651-2025

value not stated1 lot

Mon 31 Jan23:59 in Berlin

459days

Non-exclusive Drug Discount Agreement under § 130a Abs. 8 SGB V via Open-House Model for the Active Substance Latanoprost/Timolol (Official ATC-Code: S01ED61), Excluding N1, N2 and N3

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 808691-2025

value not stated1 lot

Mon 31 Jan23:59 in Berlin

459days

Conclusion of non-exclusive drug discount agreement pursuant to § 130a para. 8 SGB V via an Open-House model for the active substance Sultamicillin (WHO ATC code: J01CR04)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 845306-2025

value not stated1 lot

Tue 29 Feb23:58 in Berlin

488days

Conclusion of non-exclusive drug discount agreement pursuant to § 130a para. 8 SGB V via an Open-House model for the active substance Solifenacin/Tamsulosin (WHO ATC code: G04CA53)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 856012-2025

value not stated1 lot

Tue 29 Feb23:58 in Berlin

488days

Conclusion of non-exclusive drug discount agreement pursuant to § 130a para. 8 SGB V via an Open-House model for the active substance Fampridin (WHO ATC code: N07XX07)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 848406-2025

value not stated1 lot

Tue 29 Feb23:58 in Berlin

488days

Conclusion of non-exclusive pharmaceutical discount agreements pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance formoterol/glycopyrronium (WHO ATC code: R03AL07)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 31347-2026

value not stated1 lot

Tue 29 Feb23:58 in Berlin

488days

Conclusion of a non-exclusive pharmaceutical discount agreement pursuant to Section 130a Paragraph 8 of the Fifth Book of the German Social Code (SGB V) under an open-house model for the active substance Indacaterol/Glycopyrronium bromide (WHO ATC Code: R03AL04)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 705922-2026

value not stated1 lot

Tue 29 Feb23:58 in Berlin

488days

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 32280-2026

value not stated1 lot

Tue 29 Feb23:58 in Berlin

488days

Conclusion of non-exclusive drug discount agreement pursuant to § 130a para. 8 SGB V via an Open-House model for the active substance Aclidiniumbromid (WHO ATC code: R03BB05)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 862508-2025

value not stated1 lot

Tue 29 Feb23:59 in Berlin

488days

Drug discount agreements pursuant to § 130a Abs. 8 SGB V within the framework of Open-House procedures

IKK classic, DresdenTED 266413-2026

value not stated26 lots

Sun 5 Mar23:59 in Berlin

493days

Conclusion of a non-exclusive medicinal product discount agreement pursuant to § 130a para. 8 SGB V via an open-house model for the active substance Hydrocortisone (WHO ATC Code: H02AB09).

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 32869-2026

value not stated1 lot

Fri 31 Mar23:58 in Berlin

519days

Conclusion of a non-exclusive pharmaceutical discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active ingredient Fondaparinux (WHO ATC Code: B01AX05)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 56982-2026

value not stated1 lot

Fri 31 Mar23:58 in Berlin

519days

Conclusion of non-exclusive drug discount agreements under § 130a paragraph 8 of the German Social Security Code (SGB V) via an Open-House model for the active substance Urapidil (WHO ATC code: C02CA06)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 56028-2026

value not stated1 lot

Fri 31 Mar23:58 in Berlin

519days

Conclusion of non-exclusive drug discount agreement pursuant to § 130a, paragraph 8 of the German Social Security Code (SGB V) via an Open-House model for the active substance Vilanterol/Fluticasone (WHO ATC code: R03AK10)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 32969-2026

value not stated1 lot

Fri 31 Mar23:58 in Berlin

519days

Conclusion of non-exclusive drug discount agreement pursuant to § 130a, paragraph 8 of the German Social Security Code (SGB V) via an Open-House model for the active substance Palonosetron (WHO ATC code: A04AA05)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 60807-2026

value not stated1 lot

Fri 31 Mar23:58 in Berlin

519days

Conclusion of non-exclusive agreements for drugs with the active substance Melatonin (ATC-code: N05CH01) via an Open-House model

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 86940-2026

value not stated1 lot

Fri 31 Mar23:58 in Berlin

519days

Conclusion of non-exclusive drug discount agreements under § 130a Abs. 8 SGB V via an Open-House model for the active substance Fusidic Acid (WHO ATC-code: D06AX01)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 63792-2026

value not stated1 lot

Fri 31 Mar23:58 in Berlin

519days

Conclusion of a non-exclusive pharmaceutical discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Pegfilgrastim (WHO ATC Code: L03AA13)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 122544-2026

value not stated1 lot

Fri 31 Mar23:58 in Berlin

519days

Conclusion of non-exclusive agreements for drugs with the active substance Fremanezumab (ATC-code: N02CD03) via an Open-House model

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 88189-2026

value not stated1 lot

Fri 31 Mar23:58 in Berlin

519days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.